President and Chief Executive Officer
Michael Christman, PhD, is president and chief executive officer of the Coriell Institute for Medical Research. In 2007, Mike joined Coriell and initiated the Coriell Personalized Medicine Collaborative (CPMC), a research study evaluating the utility of using the knowledge of genetics in medicine. The CPMC project now involves more than 8,500 participants in 48 states, multiple hospital partners, and numerous research collaborators. Furthermore, the study has been awarded more than $15 million in federal grants and recognized by Nature magazine as "leading by example" in genomic medicine.
In response to the success of the CPMC, Coriell launched a for-profit spin off company - Coriell Life Sciences - to provide a comprehensive medication management tool for clinical use, and the organization was named "Global Entrepreneur of the Year" during an IBM-sponsored Silicon Valley competition featuring 1,200 start-ups.
Under Mike's leadership, Coriell has also established a federally-funded Induced Pluripotent Stem Cell lab and partnered with Cellular Dynamics International, a top for-profit reprogramming company, to win a $26 million dollar grant from the California Institute of Regenerative Medicine and establish the world's largest collection of human iPS cells.
Mike is an expert in genetics and genomics, with a focus on the integration of genome information into the delivery of clinical care. Prior to joining Coriell, he served as professor and founding chair of the Department of Genetics and Genomics for Boston University School of Medicine. There he led an international team of scientists in one of the first genome-wide association studies using the Framingham Heart Study cohort, published in Science magazine.
Mike received his bachelor's degree in chemistry with honors from the University of North Carolina, Chapel Hill, his doctorate in biochemistry from the University of California, Berkeley, and was a Jane Coffin Childs postdoctoral fellow at the Massachusetts Institute of Technology.